Gasgoo Munich- OYMotion has officially announced a strategic partnership and signed a memorandum of understanding with True Corporation, a leading Thai telecommunications giant. Moving forward, the two companies will leverage their respective core strengths to jointly develop neuro-rehabilitation solutions tailored for the Southeast Asian market, aiming to accelerate the rollout of cutting-edge rehabilitation technologies in Thailand and the broader region.
Since its founding in 2015, OYMotion has established four core technology pillars: brain-computer interfaces, electromyography (EMG) sensing, smart rehabilitation robots, and bionic dexterous hands. Its product portfolio includes smart bionic hands, rehabilitation exoskeletons, and EMG armbands. Having secured both US FDA and CE certifications, the company exports to numerous countries and regions, amassing deep technical expertise and clinical experience in the neuro-rehabilitation sector.
Image Source: OYMotion
Through this collaboration, OYMotion will bring its core capabilities in brain-computer interface neural signal decoding, precise EMG sensing interaction, and smart rehabilitation device R&D. These will be combined with True Corporation's distinct strengths in Thailand and Southeast Asia—including comprehensive 5G network coverage, a robust digital services ecosystem, and extensive local medical channel resources. Together, they aim to build a localized, intelligent, and accessible neuro-rehabilitation product and service system. The partnership will focus on three key areas:
First, the joint development of customized rehabilitation solutions. Addressing the high incidence of stroke, movement disorders, and disabilities in Southeast Asia, the partners will use 5G and AI technologies to optimize neural signal decoding efficiency. The goal is to create smart rehabilitation training systems adapted to the physiological characteristics and usage habits of local patients.
Second, launching clinical pilot validations. Leveraging True Corporation's medical partnership network, the initiative will conduct clinical trials at several top-tier hospitals in Thailand. This will accelerate the localization of products and the accumulation of clinical data, laying the groundwork for subsequent widespread rollout.
Third, driving adoption in regional markets. Using Thailand as a central hub, the partnership will gradually expand across the entire Southeast Asian region. Through technology transfer, product deployment, and supporting services, the collaboration aims to assist the digital and intelligent transformation of the Southeast Asian healthcare industry, bringing advanced rehabilitation technology to a wider population in need.
